Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Common Stock
TARA | US
5.01
USD-0.15
-2.91%
TARA | US
Loading StockChartView...
About Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/03/2026
Close
5.01
Open
5.12
High
5.23
Low
4.93
Protara Therapeutics Inc. a clinical-stage biopharmaceutical company engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002 an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics Inc. and changed its name to Protara Therapeutics Inc. in May 2020. The company is headquartered in New York New York.
View LessTARA | US
Risk
114.6
Sharpe
0.05
Luna's Score
39/100
Recommendation
Sell
Luna says (TARA | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
34.4%1 month
114.6%3 months
87.8%6 months
95.6%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.42
Debt to equity
0.05
Debt to assets
0.05
Ent. to EBITDA
0.74
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-43.90M
MarketCap
103.36M
MarketCap(USD)
103.36M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-45.91
Short ratio
13.38
Short perc.
13.83
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.14
Range1M
2.56
Range3M
2.78
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.38
Price X volume
10.47M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.74 | 0.53 | Expensive |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.42 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 87.82 | 72.80 | Riskier |
| Debt to Equity | 0.05 | -1.23 | Expensive |
| Debt to Assets | 0.05 | 0.25 | Cheaper |
| Market Cap | 103.36M | 3.66B | Emerging |
